Cell Culture Dish Podcast
The Cell Culture Dish (CCD) podcast covers areas important to the research, discovery, development, and manufacture of disease and biologic therapeutics. Key industry coverage areas include: drug discovery and development, stem cell research, cell and gene therapy, recombinant antibodies, vaccines, and emerging therapeutic modalities.
- Update frequency
- every 28 days
- Average duration
- 20 minutes
- Episodes
- 83
- Years Active
- 2016 - 2025
Computer Aided Biology Platform Helps Companies Meet the Challenges of 21st Century Biomanufacturing
In this podcast, we interviewed Markus Gershater, Chief Scientific Officer with Synthace about computer aided biology and how it addresses several common biomanufacturing challenges. We also discusse…
00:26:17 |
Tue 08 Sep 2020
Balancing Risk, Cost and Speed During Clinical Development While Still Maintaining Quality
In this podcast, we talked with Thierry Cournez Vice President, BioReliance® End-to-End Solutions, MilliporeSigma.. We discussed effective ways for emerging biotechs to collect material quickly and c…
00:11:27 |
Mon 27 Jul 2020
Solving the challenges of standardizing cell counting to ensure reproducibility in experiments, assays and manufacturing processes
Cell counting is a challenging technique, with many pitfalls, that can delay entire projects. We talk with Christian Berg about how new technologies are solving these challenges and enabling standard…
00:17:05 |
Tue 07 Jul 2020
A Look Towards the Future of 3D Cell Culture – A panel discussion
Spheroids can be an improved model for cancer in the lab compared to standard 2D cell culture. When cancer cells are cultured as spheroids, they are able to maintain the shape, polarity, genotype, an…
00:20:12 |
Wed 01 Jul 2020
Multistem – A Stable, Off-the Shelf Regenerative Medicine Has Demonstrated Promise in Treating Patients with Acute Respiratory Distress Syndrome or ARDS
In this podcast, we talked with Dr. Gil Van Bokkelen, Chairman and CEO, Athersys about recent clinical breakthroughs in regenerative medicine and manufacturing challenges. We also discussed Multistem…
00:32:41 |
Thu 04 Jun 2020
Bi-Specific Antibodies – The development, manufacture and promise of these cutting-edge therapeutics
In this podcast, we conducted a panel discussion with experts from Selexis and KBI Biopharma on bi-specific antibodies. We examined bi-specific antibody development and manufacturing, including curre…
00:32:47 |
Wed 27 May 2020
Rapid At-line Media Analyzer Speeds Process Development by Eliminating Analytics Bottleneck
In this podcast, we talked with Dr. Glenn Harris, Director of Integrated Life Sciences Platforms at 908 Devices, about the benefits and challenges of implementing rapid media analysis in process de…
00:16:48 |
Thu 14 May 2020
Non-Animal Origin cell culture supplements and manufacturing aids for biologics manufacturing
In this podcast, we talked with Dr. Tobias Hertzig, Regulatory Affairs Manager and Dr. Ulrich Tillmann, Global Product Manager, Supplements and Manufacturing Aids both representing Merck KGaA, Darmst…
00:22:10 |
Mon 11 May 2020
Mesenchymal Stem Cell Culture – Challenges and solutions for isolation, expansion and maintenance
Dr. Jennifer Chain, Scientific Director of Research and Development, Oklahoma Blood Institute, talks about the isolation of mesenchymal stem cells form cadaveric bone marrow and the differences betwe…
00:18:57 |
Wed 25 Mar 2020
CryoVault Freeze and Thaw Platform Provides a Scalable, Robust and Single-Use End-to-End Solution for Bulk Drug Substance
Max Blomberg and Andrew Govea talk about the challenges of handling bulk drug substance, specifically freeze and thaw and how the need for scalability, flexibility, and a robust approach led to the d…
00:26:37 |
Tue 11 Feb 2020
Generating actionable data and analysis in complex models using live-cell analysis
Paul Jantzen, Product Manager for IncuCyte at Sartorius talks about the benefits of real-time live-cell analysis and image processing workflows. We also discussed how live-cell analysis is enabling t…
00:14:37 |
Thu 12 Dec 2019
Improved gene therapy analytics permit monitoring of critical quality attributes and increased manufacturing efficiency
Jonathan Royce details new technologies to monitor critical quality attributes, reduce development time and increase the number of projects that can be run.
00:08:57 |
Wed 11 Dec 2019
New Advancements in Cell and Gene Therapy Implementing Precision Medicine
Dr. Paul Wotton, Chief Executive Officer, Obsidian Therapeutics talks about the evolution of cancer therapy and new advancements in the space including precision medicine. Our discussion included Obs…
00:30:45 |
Tue 10 Dec 2019
Live Cell Analysis for Neuroscience Research
In this podcast, Susana Alcantara, Senior R&D Scientist and Neuroscience Program Leader, BioAnalytics, Sartorius talks about the ways real-time live cell analysis is enabling neuroscience research. W…
00:11:48 |
Tue 29 Oct 2019
Using 3D cell-based human liver microtissue models in predicting adverse effects caused by chronic exposure to engineered nanomaterial
Shareen Doak and Dr. Wolfgang Moritz talk about the use of 3D cell-based human liver microtissue models to predict the adverse effects of chronic exposure to nanomaterial . We also discussed the use …
00:16:27 |
Sun 13 Oct 2019
Raw Material Quality – Identifying and Mitigating Variation
W interviewed Cory Card, Principal Scientist Life Sciences, GE Healthcare about raw material quality, its impact on cell culture and technologies to identify and mitigate raw material variation.
00:17:29 |
Tue 24 Sep 2019
Antibody Drug Conjugate (ADC) Development and Manufacturing Challenges and Solutions
In this podcast, we interviewed Dr. J.J. Luo, Executive Director and Dr. Lily Yin, Head of Biologics Conjugation Development, at WuXi Biologics about the state of the ADC marketplace and the challeng…
00:16:56 |
Mon 09 Sep 2019
Mustang Bio’s gene therapy has tremendous potential to cure XSCID or Bubble Boy Disease based on study results from St. Jude
In this podcast, we interviewed Dr. Manny Litchman, President and CEO, Mustang Bio and Dr. Knut Niss, Chief Technology Officer, Mustang Bio about the exciting study results for their gene therapy can…
00:14:14 |
Wed 31 Jul 2019
Successful Methods for Perfusion Process Optimization
In this podcast, we interviewed Dr. Andreas Castan, Principal Scientist at GE Healthcare Life Sciences about the best methods for optimizing perfusion processes. This included a discussion of tools f…
00:16:32 |
Wed 24 Jul 2019
How Live Cell Analysis Technology is Meeting the Needs of Ever Evolving Advanced Cell Models
In this podcast and accompanying article, we interviewed Dr. Kimberly Wicklund, Head of Product Management for the IncuCyte at Sartorius about how live cell analysis is meeting the needs of advanced …
00:16:26 |
Wed 26 Jun 2019
Disclaimer: The podcast and artwork embedded on this page are the property of Brandy Sargent. This content is not affiliated with or endorsed by eachpod.com.